-
For Clinicians & Researchers
People from African, Caribbean and Black (ACB) communities have less access to advanced treatments, like cell or organ transplant compared to White patients. ACB communities are also under-represented among regenerative medicine researchers and specialists. Finally, there is a lack of culturally responsive and safe information about these therapies for ACB communities, which creates additional barriers.
